Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.
D001437:Bacteriuria / Q000188:drug therapy* / Q000382:microbiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004149:Dioxoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D009268:Nalidixic Acid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011804:Quinolines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D014552:Urinary Tract Infections / Q000188:drug therapy
D004149:Dioxoles; D011804:Quinolines; D009268:Nalidixic Acid